As of Friday close, Bausch Health Companies Inc.’s (NYSE:BHC) stock was down -$0.17, moving down -2.03 percent to $8.22. The average number of shares traded per day over the past five days has been 6,910,040 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.30 fall in that time frame. In the last twenty days, the average volume was 3,740,030, while in the previous 50 days, it was 3,089,706.
Since last month, BHC stock rose 0.74%. Shares of the company fell to $7.56 on 09/19/23, the lowest level in the past month. A 52-week high of $10.23 was reached on 02/23/23 after having rallying from a 52-week low of $5.57. Since the beginning of this year, BHC’s stock price has risen by 30.89% or $1.94, and marked a new high 17 times. However, the stock has declined by -19.65% since its 52-week high.
BHC stock investors should be aware that Bausch Health Companies Inc. (BHC) stock had its last reported insider trading activity 17 days ago on Sep 06. Carson Seana, the EVP, General Counsel of the company, disposed of 6,685 shares for $8.28 on Sep 06. It resulted in a $55,352 divestment by the insider. Carson Seana sold 292 shares at an average price of $9.32 on Feb 28. The insider now owns 359,185 shares following the transaction.
Financial Health
In the three months ended June 29, Bausch Health Companies Inc.’s quick ratio stood at 0.80, while its current ratio was 1.10, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 70.50% percent. In the year ended June 29, EBITDA margin amounted to 34.28%, whereas operating margins totaled 16.30%. Based on annual data, BHC earned $5.76 billion in gross profit and brought in $8.12 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 6.20%. Return on equity (ROE) for the past 12 months was 27.80%.
In Bausch Health Companies Inc.’s quarter-end financial report for June 29, it reported total debt of $20.11 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. BHC’s revenue rose 9.23% to $1.94 billion during the quarter, while net income inched up to $2.17 billion. While analysts expected Bausch Health Companies Inc. to report $0.78 quarterly earnings, the actual figure was $0.82 per share, beating the consensus estimate by 5.10%. During the quarter, the company generated $739.0 million in EBITDA. The liabilities of Bausch Health Companies Inc. were 25.23 billion at the end of its most recent quarter ended June 29, and its total debt was $20.55 billion. The value of shareholders’ equity is $364.33 million.
Technical Picture
This quick technical analysis looks at Bausch Health Companies Inc.’s (BHC) price momentum. With a historical volatility rate of 61.64%, the RSI 9-day stood at 44.76% on 22 September.
With respect to its five-day moving average, the current Bausch Health Companies Inc. price is down by -3.52% percent or -$0.30. At present, BHC shares trade +1.86% above its 20-day simple moving average and +9.45% percent above its 100-day simple moving average. However, the stock is currently trading approximately -2.14% below its SMA50 and +8.87% above its SMA200.
Stochastic coefficient K was 61.52% and Stochastic coefficient D was 48.57%, while ATR was 0.37. Given the Stochastic reading of 53.66% for the 14-day period, the RSI (14) reading has been calculated as 45.42%. As of today, the MACD Oscillator reading stands at -0.07, while the 14-day reading stands at -0.11.
Analyst Ratings
Jefferies upgraded its rating on Bausch Health Companies Inc. (NYSE: BHC) to a Buy in a note to investors on September 20, 2023. The analysts firm previously had a Hold rating on the stock.Bausch Health Companies Inc. (BHC) has been rated Hold by analysts. According to 0 brokerage firms, BHC is a sell, and 4 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Bausch Health Companies Inc. stock as buy, with 1 recommending it as overweight.
With a median target price of $8.50, the current consensus forecast for the stock is $6.00 – $16.00. Based on these forecasts, analysts predict Bausch Health Companies Inc. (BHC) will achieve an average price target of $9.67.
